Fibrocor completes venture financing

On Jan. 17, fibrotic disease company Fibrocor Therapeutics L.P. (Toronto, Ontario) raised C$2.8 million ($2.1 million) in a venture round with Evotec AG and MaRS Innovation. Fibrocor said the amount i...